<scp>HYDAMTIQ</scp>, a selective <scp>PARP</scp>‐1 inhibitor, improves bleomycin‐induced lung fibrosis by dampening the <scp>TGF</scp>‐β/<scp>SMAD</scp> signalling pathway
Journal of Cellular and Molecular Medicine